Research Topic

Cognition & Brain Function

Memory, attention, executive function, and the cannabis evidence base

Cannabis has well-documented acute effects on cognition — particularly working memory, attention, and processing speed. The long-term picture is more contested: heavy adolescent use is associated with lasting cognitive deficits, while the effects of adult-onset use appear more reversible. Paradoxically, cannabinoids also show therapeutic promise for cognitive symptoms in certain neurological conditions.

1,380+ indexed studies Updated May 2026 Reviewed by MD + PhD Evidence Standards

What the Research Shows

Cognitive effects of cannabis are mediated primarily through CB1 receptor activation in the hippocampus, prefrontal cortex, and basal ganglia — regions critical for memory formation, executive function, and attention. THC acutely impairs working memory, episodic memory encoding, attention, and psychomotor speed in a dose-dependent manner. These effects are largely reversed within hours of use in occasional users. The critical question is whether heavy, long-term use causes persistent cognitive impairment. The evidence suggests a dose-response relationship: heavy daily use, particularly when initiated in adolescence, is associated with lasting deficits in verbal memory, processing speed, and executive function. Adolescent-onset use is of particular concern because the prefrontal cortex and hippocampus continue developing until the mid-20s, and CB1 receptor activation during this period may disrupt synaptic pruning and myelination. CBD, in contrast, may have neuroprotective and pro-cognitive effects — it has shown promise in attenuating THC-induced cognitive impairment and in improving cognition in conditions like schizophrenia and early Alzheimer's disease.

Key Findings

THC acutely impairs working memory and attention

Well-Studied

Dose-dependent impairment of working memory, episodic encoding, and sustained attention is among the most replicated findings in cannabis research. Effects peak 30–90 minutes post-inhalation.

Adolescent-onset use is associated with lasting cognitive deficits

Well-Studied

Multiple longitudinal studies find that cannabis use before age 16–18 is associated with lower IQ, verbal memory deficits, and reduced processing speed persisting into adulthood.

Adult-onset cognitive effects are largely reversible

Emerging Research

Most cognitive deficits in adult-onset users normalize after 28–72 days of abstinence, suggesting functional rather than structural impairment.

CBD may attenuate THC-induced cognitive impairment

Emerging Research

RCTs show CBD co-administration reduces THC-induced memory impairment and psychotomimetic effects, possibly through 5-HT1A and TRPV1 mechanisms.

Featured Studies

View all in library

Common Questions

What We Still Don't Know

These are open research questions — areas where the evidence is insufficient or actively contested.

  • 1What is the threshold of cannabis use (frequency, duration, potency) that causes lasting cognitive harm in adults?
  • 2Do high-CBD, low-THC products carry the same cognitive risk as high-THC products?
  • 3Can cognitive deficits from adolescent cannabis use be reversed with targeted interventions?
  • 4What is the long-term cognitive impact of daily medical cannabis use in older adults?
  • 5Does cannabis accelerate age-related cognitive decline or dementia onset?
  • 6Are there genetic factors (e.g., COMT, AKT1 variants) that predict cognitive vulnerability to cannabis?